Toregem BioPharma

Toregem BioPharma Focuses on Developing Antibody Drugs for Tooth RegenerationToregem BioPharma is dedicated to the research and development of antibody drugs that enable tooth regeneration. The company’s scientists have investigated the genetic causes of tooth overgrowth to aid in studying methods for adult tooth regeneration. This research demonstrates for the first time the efficacy of monoclonal antibodies in tooth regeneration, offering a new therapeutic approach to clinical problems currently addressed only through dental implants and other artificial methods.